Medical Polymers Market by Type (PVC, Polypropylene, Polyethylene, Polystyrene, Polycarbonate, PEEK, Hydrogel, Styrenic block copolymer, Rubber latex, Biodegradable, PLA, and Others), by Application (Surgical Instruments, Diagnostic Equipment, Orthopedic Implants, Electronic Implants, Dental Implants, Disposables, Packaging and Others) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022
Medical polymers are chemical compounds either single or mixture formed with the polymerization reaction. These materials are primarily used for the manufacturing of medical implants, devices, disposables, and packaging. Medical polymers are biocompatible in nature and either remain inert or are easily processed by the human body.
The medical polymers market is highly regulated and the landscape facilitates growth opportunities for the manufacturers. Government regulations play a major role in the development of medical polymer market. The initiatives taken by the government facilitates the growth of the medical polymer market. In the recent years, wide variety of medical polymers have been approved in the U.S. (FDA approval), Europe (CE mark approval), and few parts of Asia as well (MHLW approval). Medical polymers require a pre-market approval and are classified under class I (includes surgical instruments), class II (includes medical instruments), class III (includes implants), and class IV (includes pacemakers) devices. Regulatory agencies are highly concerned about the safety and efficacy of all classes and take their screening procedures at length. The stringency of these procedures therefore not only delays the launch of a device that can be highly beneficial, but also increases the expenses incurred by the manufacturers to meet the regulatory policies proposed by agencies such as the FDA and CE.
Medical polymers are classified broadly into resins, elastomers, and biodegradable plastics. Key resins that are widely utilized include polyvinyl chloride (PVC), polypropylene (PP), polyethylene (PE), polystyrene (PS), polycarbonate (PC), polyetheretherketones (PEEK), hydrogel (acrylate), acrylonitrile butadiene styrene (ABS), polymethyl methacrylate (PMMA), and polyethylene terephthalate (PET). Major elastomers employed in the medical industry include styrenic block copolymer (SBC), rubber latex thermoplastics polyurethane (TPU), and thermoplastics olefins (TPO). Frequently used biodegradable plastics include polylactic acid (PLA) and polyglycolic acid (PGA).
The market for medical polymers market is largely fragmented and comprises major industry participants such as Arkema SA, BASF SE, Covestro AG, DSM N.V., Eastman Chemical Company, Evonik Industries AG, and Solvay S.A. The market dominance of these companies is characterized by their vast product portfolio for medical polymers, high investment in R&D, and strong distribution network.
Major players operating in this market and profiled in this report include
The Medical Polymer Market is segmented as below:
By Type
The medical polymers market is highly regulated and the landscape facilitates growth opportunities for the manufacturers. Government regulations play a major role in the development of medical polymer market. The initiatives taken by the government facilitates the growth of the medical polymer market. In the recent years, wide variety of medical polymers have been approved in the U.S. (FDA approval), Europe (CE mark approval), and few parts of Asia as well (MHLW approval). Medical polymers require a pre-market approval and are classified under class I (includes surgical instruments), class II (includes medical instruments), class III (includes implants), and class IV (includes pacemakers) devices. Regulatory agencies are highly concerned about the safety and efficacy of all classes and take their screening procedures at length. The stringency of these procedures therefore not only delays the launch of a device that can be highly beneficial, but also increases the expenses incurred by the manufacturers to meet the regulatory policies proposed by agencies such as the FDA and CE.
Medical polymers are classified broadly into resins, elastomers, and biodegradable plastics. Key resins that are widely utilized include polyvinyl chloride (PVC), polypropylene (PP), polyethylene (PE), polystyrene (PS), polycarbonate (PC), polyetheretherketones (PEEK), hydrogel (acrylate), acrylonitrile butadiene styrene (ABS), polymethyl methacrylate (PMMA), and polyethylene terephthalate (PET). Major elastomers employed in the medical industry include styrenic block copolymer (SBC), rubber latex thermoplastics polyurethane (TPU), and thermoplastics olefins (TPO). Frequently used biodegradable plastics include polylactic acid (PLA) and polyglycolic acid (PGA).
The market for medical polymers market is largely fragmented and comprises major industry participants such as Arkema SA, BASF SE, Covestro AG, DSM N.V., Eastman Chemical Company, Evonik Industries AG, and Solvay S.A. The market dominance of these companies is characterized by their vast product portfolio for medical polymers, high investment in R&D, and strong distribution network.
Major players operating in this market and profiled in this report include
- Eastman Chemical Company
- Evonik Industries AG
- The Dow Chemical Company
- Formosa Plastics Corporation USA
- Arkema SA
- BASF SE
- Covestro AG
- DSM N.V.
- Solvay S.A
- Celanese Corporation
- This report provides an extensive analysis of the current and emerging market trends and dynamics in the world medical polymers market.
- Geographically, the medical polymers market is analyzed based on various regions such as North America, Europe, Asia-Pacific, and LAMEA. It also includes country analysis of major countries in each geographic region.
- This study evaluates competitive landscape and value chain to interpret the competitive environment across various geographies.
- Comprehensive analysis of factors that drive and restrict the growth of the world medical polymers market is provided.
- Exhaustive analysis of the world medical polymers market by type predicts the major material used currently along with the ones that would gain prominence in the future.
- Extensive analysis of the market is conducted by following key product positioning and monitoring the top competitors within the framework.
The Medical Polymer Market is segmented as below:
By Type
- Resin
- Polyvinyl chloride (PVC)
- Polypropylene (PP)
- Polyethylene (PE)
- Polystyrene (PS)
- Polycarbonate (PC)
- Polyetheretherketones (PEEK)
- Hydrogel (Acrylate)
- Others (Including ABS, PMMA and PET)
- Elastomer
- Styrenic block copolymer (SBC)
- Rubber latex
- Others (Including TPU, TPV and TPO)
- Biodegradable
- Plastics
- Devices
- Surgical Instruments
- Diagnostic Equipment
- Others
- Implant
- Orthopaedic Implants
- Electronic Implants
- Dental Implants
- Disposables
- Packaging
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
- LAMEA
- Latin America
- Middle East
- Africa
- Rest of LAMEA
- Victrex Plc.
- DuPont
- Tianjin Plastics Research Institute Co. Ltd,
- Lubrizol Corporation
- Bayer
CHAPTER 1 INTRODUCTION
1.1 Report Description
1.2 Key Benefits
1.3 Key Market Trends
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO Perspective
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key Findings
3.2.1 Top Investment Pockets
3.2.2 Top Player Positioning
3.3 Porters Five Forces Analysis
3.3.1 Bargaining Power of Suppliers
3.3.2 Bargaining Power of Buyers
3.3.3 Threat of New Entrants
3.3.4 Threat of Substitutes
3.3.5 Competitive Rivalry
3.4 Regulatory Scenario
3.4.1 U.S. FDA
3.4.2 Europe CE Mark
3.4.3 Ministry of Health, Labour and Welfare (MHLW)
3.5 Market dynamics
3.5.1 Drivers
3.5.1.1 Increase in adoption of MEDICAL Polymers owing to low prices and versatility
3.5.1.2 growth in sales of Medical Implants and Devices
3.5.1.3 Rise in Number of FDA Approvals for Performing Clinical Trials to Benefit the Market
3.5.2 Restraints
3.5.2.1 Price volatility and supply constraints
3.5.2.2 Stringent approval process
3.5.3 Opportunities
3.5.3.1 Funding and grants create market opportunities worldwide
3.5.3.2 Patents in biosorbable polymers increasing by more than 30% per year
3.6 Top Winning Strategies
CHAPTER 4 WORLD MEDICAL POLYMERS MARKET, BY TYPE
4.1 Introduction
4.1.1 Market Size and Forecast
4.2 Resins
4.2.1 Key markets trend
4.2.2 Key growth factors and opportunity
4.2.3 Market Size and Forecast
4.3 Elastomers
4.3.1 Key markets trend
4.3.2 Key growth factors and opportunity
4.3.3 Market Size and Forecast
4.4 Biodegradable plastics
4.4.1 Key markets trends
4.4.2 Key growth factors and opportunity
4.4.3 Market Size and Forecast
CHAPTER 5 WORLD MEDICAL POLYMERS MARKET, BY APPLICATION
5.1 Introduction
5.1.1 Market size and forecast
5.2 Devices
5.2.1 Surgical instruments
5.2.1.1 Market size and forecast
5.2.2 Diagnostics equipment
5.2.2.1 Market size and forecast
5.2.3 Others
5.2.3.1 Market size and forecast
5.3 Implants
5.3.1 Market size and forecast
5.3.2 Orthopedic implants
5.3.2.1 Market size and forecast
5.3.3 Electronic implants
5.3.3.1 Market size and forecast
5.3.4 Dental implants
5.3.4.1 Market size and forecast
5.4 Disposables
5.4.1 Market size and forecast
5.5 Packaging
5.5.1 Market size and forecast
CHAPTER 6 WORLD MEDICAL POLYMERS MARKET, BY GEOGRAPHY
6.1 Introduction
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.2.4 U. S.
6.2.4.1 Market size and forecast
6.2.5 Canada
6.2.5.1 market size and forecast
6.2.6 Mexico
6.2.6.1 market size and forecast
6.3 Europe
6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
6.3.4 Germany
6.3.4.1 Market size and forecast
6.3.5 France
6.3.5.1 market size and forecast
6.3.6 UK
6.3.6.1 market size and forecast
6.3.7 Rest of Europe
6.3.7.1 market size and forecast
6.4 Asia-Pacific
6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast
6.4.4 Japan
6.4.4.1 Market size and forecast
6.4.5 China
6.4.5.1 market size and forecast
6.4.6 India
6.4.6.1 market size and forecast
6.4.7 Rest of Asia-Pacific
6.4.7.1 market size and forecast
6.5 LAMEA
6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast
6.5.4 Latin America
6.5.4.1 Market size and forecast
6.5.5 Middle East
6.5.5.1 market size and forecast
6.5.6 Africa
6.5.6.1 market size and forecast
CHAPTER 7 COMPANY PROFILES
7.1 Eastman Chemical Company
7.1.1 Company overview
7.1.2 Operating business segments
7.1.3 Business performance
7.1.4 Key strategic moves & development
7.2 Evonik Industries AG
7.2.1 Company overview
7.2.2 Operating business segments
7.2.3 Business performance
7.2.4 Key strategic moves & development
7.3 The Dow Chemical Company
7.3.1 Company overview
7.3.2 Operating business segments
7.3.3 Business performance
7.3.4 Key strategic moves & development
7.4 Formosa Plastics Corporation USA
7.4.1 Company overview
7.4.2 Operating business segments
7.4.3 Business performance
7.4.4 Key strategic moves & development
7.5 Arkema SA
7.5.1 Company overview
7.5.2 Operating business segments
7.5.3 Business performance
7.5.4 Key strategic moves & development
7.6 BASF SE
7.6.1 Company overview
7.6.2 Operating business segments
7.6.3 Business performance
7.6.4 Key strategic moves & development
7.7 Covestro AG
7.7.1 Company overview
7.7.2 Operating business segments
7.7.3 Business performance
7.7.4 Key strategic moves & development
7.8 DSM N.V.
7.8.1 Company overview
7.8.2 Operating business segments
7.8.3 Business performance
7.8.4 Key strategic moves & development
7.9 Solvay S.A
7.9.1 Company overview
7.9.2 Operating business segments
7.9.3 Business performance
7.9.4 Key strategic moves & development
7.10 Celanese Corporation
7.10.1 Company overview
7.10.2 Operating business segments
7.10.3 Business performance
7.10.4 Key strategic moves & development
Other major players in the industry includes
Victrex Plc.
DuPont
Tianjin Plastics Research Institute Co. Ltd, Lubrizol Corporation
Bayer
Profiles of these players are not included. The same will be included on request
1.1 Report Description
1.2 Key Benefits
1.3 Key Market Trends
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO Perspective
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key Findings
3.2.1 Top Investment Pockets
3.2.2 Top Player Positioning
3.3 Porters Five Forces Analysis
3.3.1 Bargaining Power of Suppliers
3.3.2 Bargaining Power of Buyers
3.3.3 Threat of New Entrants
3.3.4 Threat of Substitutes
3.3.5 Competitive Rivalry
3.4 Regulatory Scenario
3.4.1 U.S. FDA
3.4.2 Europe CE Mark
3.4.3 Ministry of Health, Labour and Welfare (MHLW)
3.5 Market dynamics
3.5.1 Drivers
3.5.1.1 Increase in adoption of MEDICAL Polymers owing to low prices and versatility
3.5.1.2 growth in sales of Medical Implants and Devices
3.5.1.3 Rise in Number of FDA Approvals for Performing Clinical Trials to Benefit the Market
3.5.2 Restraints
3.5.2.1 Price volatility and supply constraints
3.5.2.2 Stringent approval process
3.5.3 Opportunities
3.5.3.1 Funding and grants create market opportunities worldwide
3.5.3.2 Patents in biosorbable polymers increasing by more than 30% per year
3.6 Top Winning Strategies
CHAPTER 4 WORLD MEDICAL POLYMERS MARKET, BY TYPE
4.1 Introduction
4.1.1 Market Size and Forecast
4.2 Resins
4.2.1 Key markets trend
4.2.2 Key growth factors and opportunity
4.2.3 Market Size and Forecast
4.3 Elastomers
4.3.1 Key markets trend
4.3.2 Key growth factors and opportunity
4.3.3 Market Size and Forecast
4.4 Biodegradable plastics
4.4.1 Key markets trends
4.4.2 Key growth factors and opportunity
4.4.3 Market Size and Forecast
CHAPTER 5 WORLD MEDICAL POLYMERS MARKET, BY APPLICATION
5.1 Introduction
5.1.1 Market size and forecast
5.2 Devices
5.2.1 Surgical instruments
5.2.1.1 Market size and forecast
5.2.2 Diagnostics equipment
5.2.2.1 Market size and forecast
5.2.3 Others
5.2.3.1 Market size and forecast
5.3 Implants
5.3.1 Market size and forecast
5.3.2 Orthopedic implants
5.3.2.1 Market size and forecast
5.3.3 Electronic implants
5.3.3.1 Market size and forecast
5.3.4 Dental implants
5.3.4.1 Market size and forecast
5.4 Disposables
5.4.1 Market size and forecast
5.5 Packaging
5.5.1 Market size and forecast
CHAPTER 6 WORLD MEDICAL POLYMERS MARKET, BY GEOGRAPHY
6.1 Introduction
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.2.4 U. S.
6.2.4.1 Market size and forecast
6.2.5 Canada
6.2.5.1 market size and forecast
6.2.6 Mexico
6.2.6.1 market size and forecast
6.3 Europe
6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
6.3.4 Germany
6.3.4.1 Market size and forecast
6.3.5 France
6.3.5.1 market size and forecast
6.3.6 UK
6.3.6.1 market size and forecast
6.3.7 Rest of Europe
6.3.7.1 market size and forecast
6.4 Asia-Pacific
6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast
6.4.4 Japan
6.4.4.1 Market size and forecast
6.4.5 China
6.4.5.1 market size and forecast
6.4.6 India
6.4.6.1 market size and forecast
6.4.7 Rest of Asia-Pacific
6.4.7.1 market size and forecast
6.5 LAMEA
6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast
6.5.4 Latin America
6.5.4.1 Market size and forecast
6.5.5 Middle East
6.5.5.1 market size and forecast
6.5.6 Africa
6.5.6.1 market size and forecast
CHAPTER 7 COMPANY PROFILES
7.1 Eastman Chemical Company
7.1.1 Company overview
7.1.2 Operating business segments
7.1.3 Business performance
7.1.4 Key strategic moves & development
7.2 Evonik Industries AG
7.2.1 Company overview
7.2.2 Operating business segments
7.2.3 Business performance
7.2.4 Key strategic moves & development
7.3 The Dow Chemical Company
7.3.1 Company overview
7.3.2 Operating business segments
7.3.3 Business performance
7.3.4 Key strategic moves & development
7.4 Formosa Plastics Corporation USA
7.4.1 Company overview
7.4.2 Operating business segments
7.4.3 Business performance
7.4.4 Key strategic moves & development
7.5 Arkema SA
7.5.1 Company overview
7.5.2 Operating business segments
7.5.3 Business performance
7.5.4 Key strategic moves & development
7.6 BASF SE
7.6.1 Company overview
7.6.2 Operating business segments
7.6.3 Business performance
7.6.4 Key strategic moves & development
7.7 Covestro AG
7.7.1 Company overview
7.7.2 Operating business segments
7.7.3 Business performance
7.7.4 Key strategic moves & development
7.8 DSM N.V.
7.8.1 Company overview
7.8.2 Operating business segments
7.8.3 Business performance
7.8.4 Key strategic moves & development
7.9 Solvay S.A
7.9.1 Company overview
7.9.2 Operating business segments
7.9.3 Business performance
7.9.4 Key strategic moves & development
7.10 Celanese Corporation
7.10.1 Company overview
7.10.2 Operating business segments
7.10.3 Business performance
7.10.4 Key strategic moves & development
Other major players in the industry includes
Victrex Plc.
DuPont
Tianjin Plastics Research Institute Co. Ltd, Lubrizol Corporation
Bayer
Profiles of these players are not included. The same will be included on request
LIST OF TABLES
TABLE 1 PRICES OF MAJOR MEDICAL POLYMERS
TABLE 2 WORLD MEDICAL POLYMERS MARKET, BY TYPE, 2014-2022 (KILO TONS)
TABLE 3 WORLD MEDICAL POLYMERS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 4 WORLD RESINS MARKET, 2014-2022 (KILO TONS)
TABLE 5 WORLD RESINS MARKET, 2014-2022 ($MILLION)
TABLE 6 WORLD ELASTOMERS MARKET, 2014-2022 (KILO TONS)
TABLE 7 WORLD ELASTOMER MARKET, 2014-2022 ($MILLION)
TABLE 8 WORLD BIODEGRADABLE PLASTICS MARKET, 2014-2022 (KILO TONS)
TABLE 9 WORLD BIODEGRADABLE PLASTICS MARKET, 2014-2022 ($MILLION)
TABLE 10 WORLD MEDICAL POLYMERS MARKET, BY APPLICATION, 2014-2022 (KILO TONS)
TABLE 11 WORLD MEDICAL POLYMERS MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 12 WORLD MEDICAL POLYMER SURGICAL INSTRUMENTS MARKET, 2014-2022 (KILO TONS)
TABLE 13 WORLD MEDICAL POLYMER SURGICAL INSTRUMENTS MARKET, 2014-2022 ($MILLION)
TABLE 14 WORLD MEDICAL POLYMER DIAGNOSTICS EQUIPMENT MARKET, 2014-2022 (KILO TONS)
TABLE 15 WORLD MEDICAL POLYMER DIAGNOSTICS EQUIPMENT MARKET, 2014-2022 ($MILLION)
TABLE 16 WORLD MEDICAL POLYMER OTHERS MARKET, 2014-2022 (KILO TONS)
TABLE 17 WORLD MEDICAL POLYMER OTHERS MARKET, 2014-2022 ($MILLION)
TABLE 18 LIST OF FEW FDA-APPROVED IMPLANTABLE MEDICAL DEVICES MANUFACTURED USING POLYMERS
TABLE 19 WORLD MEDICAL POLYMER IMPLANTS MARKET, 2014-2022 (KILO TONS)
TABLE 20 WORLD MEDICAL POLYMER IMPLANTS MARKET, 2014-2022 ($MILLION)
TABLE 21 WORLD MEDICAL POLYMER ORTHOPEDIC IMPLANTS MARKET, 2014-2022 (KILO TONS)
TABLE 22 WORLD MEDICAL POLYMER ORTHOPEDIC IMPLANTS MARKET, 2014-2022 ($MILLION)
TABLE 23 WORLD MEDICAL POLYMER ELECTRONIC IMPLANTS MARKET, 2014-2022 (KILO TONS)
TABLE 24 WORLD MEDICAL POLYMER ELECTRONIC IMPLANTS MARKET, 2014-2022 ($MILLION)
TABLE 25 WORLD MEDICAL POLYMER DENTAL IMPLANTS MARKET, 2014-2022 (KILO TONS)
TABLE 26 WORLD MEDICAL POLYMER DENTAL IMPLANTS MARKET, 2014-2022 ($MILLION)
TABLE 27 WORLD MEDICAL POLYMER DISPOSABLE MARKET 2014-2022 (KILO TONS)
TABLE 28 WORLD MEDICAL POLYMER DISPOSABLE MARKET 2014-2022 ($MILLION)
TABLE 29 WORLD MEDICAL POLYMER PACKAGING MARKET, 2014-2022 (KILO TONS)
TABLE 30 WORLD MEDICAL POLYMER PACKAGING MARKET, 2014-2022 ($MILLION)
TABLE 31 WORLD MEDICAL POLYMERS MARKET, BY GEOGRAPHY 2014-2022 (KILO TONS)
TABLE 32 WORLD MEDICAL POLYMERS MARKET, BY GEOGRAPHY 2014-2022 ($MILLION)
TABLE 33 NORTH AMERICA MEDICAL POLYMERS MARKET, BY TYPE, 2014-2022 (KILO TONS)
TABLE 34 NORTH AMERICA MEDICAL POLYMERS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 35 NORTH AMERICA MEDICAL POLYMERS MARKET, BY APPLICATION, 2014-2022 (KILO TONS)
TABLE 36 NORTH AMERICA MEDICAL POLYMERS MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 37 NORTH AMERICA MEDICAL POLYMERS MARKET, BY COUNTRY, 2014-2022 (KILO TONS)
TABLE 38 NORTH AMERICA MEDICAL POLYMERS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 39 EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2014-2022 (KILO TONS)
TABLE 40 EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 41 EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2014-2022 (KILO TONS)
TABLE 42 EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 43 EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2014-2022 (KILO TONS)
TABLE 44 EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 45 ASIA-PACIFIC MEDICAL POLYMERS MARKET, BY TYPE, 2014-2022 (KILO TONS)
TABLE 46 ASIA-PACIFIC MEDICAL POLYMERS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 47 ASIA-PACIFIC MEDICAL POLYMERS MARKET, BY APPLICATION, 2014-2022 (KILO TONS)
TABLE 48 ASIA-PACIFIC MEDICAL POLYMERS MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 49 ASIA-PACIFIC MEDICAL POLYMERS MARKET, BY COUNTRY, 2014-2022 (KILO TONS)
TABLE 50 ASIA-PACIFIC MEDICAL POLYMERS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 51 LAMEA MEDICAL POLYMER MARKET, BY TYPE, 2014-2022 (KILO TONS)
TABLE 52 LAMEA MEDICAL POLYMER MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 53 LAMEA MEDICAL POLYMER MARKET, BY APPLICATION, 2014-2022 (KILO TONS)
TABLE 54 LAMEA MEDICAL POLYMER MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 55 LAMEA MEDICAL POLYMER MARKET, BY COUNTRY, 2014-2022 (KILO TONS)
TABLE 56 LAMEA MEDICAL POLYMER MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 57 EASTMAN CHEMICAL COMPANY: COMPANY SNAPSHOT
TABLE 58 EASTMAN CHEMICAL COMPANY: OPERATING SEGMENT
TABLE 59 EVONIK INDUSTRIES AG: COMPANY SNAPSHOT
TABLE 60 EVONIK INDUSTRIES AG: OPERATING SEGMENTS
TABLE 61 THE DOW CHEMICAL COMPANY: COMPANY SNAPSHOT
TABLE 62 THE DOW CHEMICAL COMPANY: OPERATING SEGMENTS
TABLE 63 FORMOSA PLASTICS CORPORATION USA: COMPANY SNAPSHOT
TABLE 64 FORMOSA PLASTICS CORPORATION USA: OPERATING SEGMENTS
TABLE 65 ARKEMA SA: COMPANY SNAPSHOT
TABLE 66 ARKEMA SA: OPERATING SEGMENTS
TABLE 67 BASF SE: COMPANY SNAPSHOT
TABLE 68 BASF SE: OPERATING SEGMENTS
TABLE 69 COVESTRO AG: COMPANY SNAPSHOT
TABLE 70 COVESTRO AG: OPERATING SEGMENTS
TABLE 71 DSM N. V.: COMPANY SNAPSHOT
TABLE 72 DSM N. V.: OPERATING SEGMENTS
TABLE 73 SOLVAY S.A: COMPANY SNAPSHOT
TABLE 74 SOLVAY S.A: OPERATING SEGMENT
TABLE 75 CELANESE CORPORATION: COMPANY SNAPSHOT
TABLE 76 CELANESE CORPORATION: OPERATING SEGMENTS
TABLE 1 PRICES OF MAJOR MEDICAL POLYMERS
TABLE 2 WORLD MEDICAL POLYMERS MARKET, BY TYPE, 2014-2022 (KILO TONS)
TABLE 3 WORLD MEDICAL POLYMERS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 4 WORLD RESINS MARKET, 2014-2022 (KILO TONS)
TABLE 5 WORLD RESINS MARKET, 2014-2022 ($MILLION)
TABLE 6 WORLD ELASTOMERS MARKET, 2014-2022 (KILO TONS)
TABLE 7 WORLD ELASTOMER MARKET, 2014-2022 ($MILLION)
TABLE 8 WORLD BIODEGRADABLE PLASTICS MARKET, 2014-2022 (KILO TONS)
TABLE 9 WORLD BIODEGRADABLE PLASTICS MARKET, 2014-2022 ($MILLION)
TABLE 10 WORLD MEDICAL POLYMERS MARKET, BY APPLICATION, 2014-2022 (KILO TONS)
TABLE 11 WORLD MEDICAL POLYMERS MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 12 WORLD MEDICAL POLYMER SURGICAL INSTRUMENTS MARKET, 2014-2022 (KILO TONS)
TABLE 13 WORLD MEDICAL POLYMER SURGICAL INSTRUMENTS MARKET, 2014-2022 ($MILLION)
TABLE 14 WORLD MEDICAL POLYMER DIAGNOSTICS EQUIPMENT MARKET, 2014-2022 (KILO TONS)
TABLE 15 WORLD MEDICAL POLYMER DIAGNOSTICS EQUIPMENT MARKET, 2014-2022 ($MILLION)
TABLE 16 WORLD MEDICAL POLYMER OTHERS MARKET, 2014-2022 (KILO TONS)
TABLE 17 WORLD MEDICAL POLYMER OTHERS MARKET, 2014-2022 ($MILLION)
TABLE 18 LIST OF FEW FDA-APPROVED IMPLANTABLE MEDICAL DEVICES MANUFACTURED USING POLYMERS
TABLE 19 WORLD MEDICAL POLYMER IMPLANTS MARKET, 2014-2022 (KILO TONS)
TABLE 20 WORLD MEDICAL POLYMER IMPLANTS MARKET, 2014-2022 ($MILLION)
TABLE 21 WORLD MEDICAL POLYMER ORTHOPEDIC IMPLANTS MARKET, 2014-2022 (KILO TONS)
TABLE 22 WORLD MEDICAL POLYMER ORTHOPEDIC IMPLANTS MARKET, 2014-2022 ($MILLION)
TABLE 23 WORLD MEDICAL POLYMER ELECTRONIC IMPLANTS MARKET, 2014-2022 (KILO TONS)
TABLE 24 WORLD MEDICAL POLYMER ELECTRONIC IMPLANTS MARKET, 2014-2022 ($MILLION)
TABLE 25 WORLD MEDICAL POLYMER DENTAL IMPLANTS MARKET, 2014-2022 (KILO TONS)
TABLE 26 WORLD MEDICAL POLYMER DENTAL IMPLANTS MARKET, 2014-2022 ($MILLION)
TABLE 27 WORLD MEDICAL POLYMER DISPOSABLE MARKET 2014-2022 (KILO TONS)
TABLE 28 WORLD MEDICAL POLYMER DISPOSABLE MARKET 2014-2022 ($MILLION)
TABLE 29 WORLD MEDICAL POLYMER PACKAGING MARKET, 2014-2022 (KILO TONS)
TABLE 30 WORLD MEDICAL POLYMER PACKAGING MARKET, 2014-2022 ($MILLION)
TABLE 31 WORLD MEDICAL POLYMERS MARKET, BY GEOGRAPHY 2014-2022 (KILO TONS)
TABLE 32 WORLD MEDICAL POLYMERS MARKET, BY GEOGRAPHY 2014-2022 ($MILLION)
TABLE 33 NORTH AMERICA MEDICAL POLYMERS MARKET, BY TYPE, 2014-2022 (KILO TONS)
TABLE 34 NORTH AMERICA MEDICAL POLYMERS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 35 NORTH AMERICA MEDICAL POLYMERS MARKET, BY APPLICATION, 2014-2022 (KILO TONS)
TABLE 36 NORTH AMERICA MEDICAL POLYMERS MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 37 NORTH AMERICA MEDICAL POLYMERS MARKET, BY COUNTRY, 2014-2022 (KILO TONS)
TABLE 38 NORTH AMERICA MEDICAL POLYMERS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 39 EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2014-2022 (KILO TONS)
TABLE 40 EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 41 EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2014-2022 (KILO TONS)
TABLE 42 EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 43 EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2014-2022 (KILO TONS)
TABLE 44 EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 45 ASIA-PACIFIC MEDICAL POLYMERS MARKET, BY TYPE, 2014-2022 (KILO TONS)
TABLE 46 ASIA-PACIFIC MEDICAL POLYMERS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 47 ASIA-PACIFIC MEDICAL POLYMERS MARKET, BY APPLICATION, 2014-2022 (KILO TONS)
TABLE 48 ASIA-PACIFIC MEDICAL POLYMERS MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 49 ASIA-PACIFIC MEDICAL POLYMERS MARKET, BY COUNTRY, 2014-2022 (KILO TONS)
TABLE 50 ASIA-PACIFIC MEDICAL POLYMERS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 51 LAMEA MEDICAL POLYMER MARKET, BY TYPE, 2014-2022 (KILO TONS)
TABLE 52 LAMEA MEDICAL POLYMER MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 53 LAMEA MEDICAL POLYMER MARKET, BY APPLICATION, 2014-2022 (KILO TONS)
TABLE 54 LAMEA MEDICAL POLYMER MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 55 LAMEA MEDICAL POLYMER MARKET, BY COUNTRY, 2014-2022 (KILO TONS)
TABLE 56 LAMEA MEDICAL POLYMER MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 57 EASTMAN CHEMICAL COMPANY: COMPANY SNAPSHOT
TABLE 58 EASTMAN CHEMICAL COMPANY: OPERATING SEGMENT
TABLE 59 EVONIK INDUSTRIES AG: COMPANY SNAPSHOT
TABLE 60 EVONIK INDUSTRIES AG: OPERATING SEGMENTS
TABLE 61 THE DOW CHEMICAL COMPANY: COMPANY SNAPSHOT
TABLE 62 THE DOW CHEMICAL COMPANY: OPERATING SEGMENTS
TABLE 63 FORMOSA PLASTICS CORPORATION USA: COMPANY SNAPSHOT
TABLE 64 FORMOSA PLASTICS CORPORATION USA: OPERATING SEGMENTS
TABLE 65 ARKEMA SA: COMPANY SNAPSHOT
TABLE 66 ARKEMA SA: OPERATING SEGMENTS
TABLE 67 BASF SE: COMPANY SNAPSHOT
TABLE 68 BASF SE: OPERATING SEGMENTS
TABLE 69 COVESTRO AG: COMPANY SNAPSHOT
TABLE 70 COVESTRO AG: OPERATING SEGMENTS
TABLE 71 DSM N. V.: COMPANY SNAPSHOT
TABLE 72 DSM N. V.: OPERATING SEGMENTS
TABLE 73 SOLVAY S.A: COMPANY SNAPSHOT
TABLE 74 SOLVAY S.A: OPERATING SEGMENT
TABLE 75 CELANESE CORPORATION: COMPANY SNAPSHOT
TABLE 76 CELANESE CORPORATION: OPERATING SEGMENTS
LIST OF FIGURES
FIG. 1 TOP INVESTMENT POCKETS MEDICAL POLYMERS
FIG. 2 TOP PLAYER POSITIONING MEDICAL POLYMERS
FIG. 3 PORTERS FIVE FORCES ANALYSIS
FIG. 4 TOP FACTORS IMPACTING THE MEDICAL POLYMERS MARKET
FIG. 5 TOP FACTORS IMPACTING GLOBAL MEDICAL IMPLANTS AND DEVICES MARKET
FIG. 6 LIST OF FEW MEDICAL DEVICES MADE FROM POLYMERS
FIG. 7 U.S.: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 8 CANADA: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 9 MEXICO: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 10 GERMANY: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 11 FRANCE: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 12 UK: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 13 REST OF EUROPE: MEDICAL POLYMERS MARKET 2014-2022
FIG. 14 JAPAN: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 15 CHINA: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 16 INDIA: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 17 REST OF ASIA-PACIFIC: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 18 LATIN AMERICA: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 19 MIDDLE EAST: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 20 AFRICA: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 21 EASTMAN CHEMICAL COMPANY: REVENUE, 2013-2015 ($MILLION)
FIG. 22 EASTMAN CHEMICAL COMPANY: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 23 EASTMAN CHEMICAL COMPANY: REVENUE, BY GEOGRAPHY (%)
FIG. 24 EVONIK INDUSTRIES AG: REVENUE, 2013-2015 ($MILLION)
FIG. 25 EVONIK INDUSTRIES AG: REVENUE, BY BUSINESS SEGMENT 2015 (%)
FIG. 26 EVONIK INDUSTRIES AG: REVENUE, BY GEOGRAPHY 2015 (%)
FIG. 27 THE DOW CHEMICAL COMPANY: REVENUE, 2013-2015 ($MILLION)
FIG. 28 THE DOW CHEMICAL COMPANY: REVENUE, BY SEGMENTS 2015 (%)
FIG. 29 THE DOW CHEMICAL COMPANY: REVENUE, BY GEOGRAPHY 2015 (%)
FIG. 30 FORMOSA PLASTICS CORPORATION USA: REVENUE, 2013-2015 ($MILLION)
FIG. 31 FORMOSA PLASTICS CORPORATION USA: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 32 FORMOSA PLASTICS CORPORATION USA: REVENUE, BY GEOGRAPHY SEGMENT, 2015 (%)
FIG. 33 ARKEMA SA: REVENUE, 2013-2015 ($MILLION)
FIG. 34 ARKEMA SA: REVENUE, BY SEGMENT, 2015 (%)
FIG. 35 ARKEMA SA: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 36 BASF SE: REVENUE, 2013-2015 ($MILLION)
FIG. 37 BASF SE: REVENUE, BY SEGMENT, 2015 (%)
FIG. 38 BASF SE: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 39 COVESTRO AG: REVENUE, 2013-2015 ($MILLION)
FIG. 40 COVESTRO AG: REVENUE, BY SEGMENT, 2015 (%)
FIG. 41 COVESTRO AG: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 42 DSM N. V.: REVENUE, 2013-2015 ($MILLION)
FIG. 43 DSM N. V.: REVENUE, BY SEGMENT, 2015 (%)
FIG. 44 DSM N. V.: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 45 SOLVAY S.A: REVENUE, 2013-2015 ($MILLION)
FIG. 46 SOLVAY S.A: REVENUE, BY SEGMENT, 2015 (%)
FIG. 47 SOLVAY S.A: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 48 CELANESE CORPORATION: REVENUE, 2013-2015 ($MILLION)
FIG. 49 CELANESE CORPORATION: REVENUE, BY SEGMENT, 2015 (%)
FIG. 50 CELANESE CORPORATION: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 1 TOP INVESTMENT POCKETS MEDICAL POLYMERS
FIG. 2 TOP PLAYER POSITIONING MEDICAL POLYMERS
FIG. 3 PORTERS FIVE FORCES ANALYSIS
FIG. 4 TOP FACTORS IMPACTING THE MEDICAL POLYMERS MARKET
FIG. 5 TOP FACTORS IMPACTING GLOBAL MEDICAL IMPLANTS AND DEVICES MARKET
FIG. 6 LIST OF FEW MEDICAL DEVICES MADE FROM POLYMERS
FIG. 7 U.S.: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 8 CANADA: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 9 MEXICO: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 10 GERMANY: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 11 FRANCE: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 12 UK: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 13 REST OF EUROPE: MEDICAL POLYMERS MARKET 2014-2022
FIG. 14 JAPAN: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 15 CHINA: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 16 INDIA: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 17 REST OF ASIA-PACIFIC: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 18 LATIN AMERICA: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 19 MIDDLE EAST: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 20 AFRICA: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 21 EASTMAN CHEMICAL COMPANY: REVENUE, 2013-2015 ($MILLION)
FIG. 22 EASTMAN CHEMICAL COMPANY: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 23 EASTMAN CHEMICAL COMPANY: REVENUE, BY GEOGRAPHY (%)
FIG. 24 EVONIK INDUSTRIES AG: REVENUE, 2013-2015 ($MILLION)
FIG. 25 EVONIK INDUSTRIES AG: REVENUE, BY BUSINESS SEGMENT 2015 (%)
FIG. 26 EVONIK INDUSTRIES AG: REVENUE, BY GEOGRAPHY 2015 (%)
FIG. 27 THE DOW CHEMICAL COMPANY: REVENUE, 2013-2015 ($MILLION)
FIG. 28 THE DOW CHEMICAL COMPANY: REVENUE, BY SEGMENTS 2015 (%)
FIG. 29 THE DOW CHEMICAL COMPANY: REVENUE, BY GEOGRAPHY 2015 (%)
FIG. 30 FORMOSA PLASTICS CORPORATION USA: REVENUE, 2013-2015 ($MILLION)
FIG. 31 FORMOSA PLASTICS CORPORATION USA: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 32 FORMOSA PLASTICS CORPORATION USA: REVENUE, BY GEOGRAPHY SEGMENT, 2015 (%)
FIG. 33 ARKEMA SA: REVENUE, 2013-2015 ($MILLION)
FIG. 34 ARKEMA SA: REVENUE, BY SEGMENT, 2015 (%)
FIG. 35 ARKEMA SA: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 36 BASF SE: REVENUE, 2013-2015 ($MILLION)
FIG. 37 BASF SE: REVENUE, BY SEGMENT, 2015 (%)
FIG. 38 BASF SE: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 39 COVESTRO AG: REVENUE, 2013-2015 ($MILLION)
FIG. 40 COVESTRO AG: REVENUE, BY SEGMENT, 2015 (%)
FIG. 41 COVESTRO AG: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 42 DSM N. V.: REVENUE, 2013-2015 ($MILLION)
FIG. 43 DSM N. V.: REVENUE, BY SEGMENT, 2015 (%)
FIG. 44 DSM N. V.: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 45 SOLVAY S.A: REVENUE, 2013-2015 ($MILLION)
FIG. 46 SOLVAY S.A: REVENUE, BY SEGMENT, 2015 (%)
FIG. 47 SOLVAY S.A: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 48 CELANESE CORPORATION: REVENUE, 2013-2015 ($MILLION)
FIG. 49 CELANESE CORPORATION: REVENUE, BY SEGMENT, 2015 (%)
FIG. 50 CELANESE CORPORATION: REVENUE, BY GEOGRAPHY, 2015 (%)
